Dasch James R, Dasch Amy L
Cold Spring Harb Protoc. 2017 Aug 1;2017(8):pdb.prot093856. doi: 10.1101/pdb.prot093856.
Modern molecular biology techniques have been applied to the production of therapeutic antibodies. Nonetheless, recombinant antibodies remain the exception rather than the rule for the antibodies used in most research and diagnostic applications. The lack of penetration of recombinant antibodies into the research arena can be attributed largely to the fact that the Ig gene families are large and the variable region gene segments are, indeed, variable, precluding the use of polymerase chain reaction (PCR) with two simple primers to amplify the heavy and light chain gene segments. Because of the complexity of the V gene family and the number of possible sequences for amplification, there may be a distinct advantage to using a PCR method that does not require a specific 5' primer to amplify the gene segment. 5'-RACE is just such a method. In the original 5'-RACE method, mRNA served as a template for cDNA synthesis using either oligo(dT) priming or a gene-specific primer. Terminal deoxynucleotide transferase (TdT) was used to tail the first strand with a region of known sequence, such as poly(A). Once tailed, the second strand can be amplified using poly(T). This 5'-RACE protocol uses the TdT activity of reverse transcriptase, which allows nontemplated addition of nucleotides to the end of the nascently made cDNA first strand.
现代分子生物学技术已应用于治疗性抗体的生产。尽管如此,重组抗体在大多数研究和诊断应用中所使用的抗体中仍是例外而非常规。重组抗体在研究领域缺乏广泛应用,很大程度上可归因于免疫球蛋白(Ig)基因家族庞大,且可变区基因片段确实具有多样性,这使得无法使用两条简单引物通过聚合酶链反应(PCR)来扩增重链和轻链基因片段。由于V基因家族的复杂性以及可能的扩增序列数量众多,使用一种不需要特定5'引物来扩增基因片段的PCR方法可能具有明显优势。5'-RACE就是这样一种方法。在最初的5'-RACE方法中,mRNA作为模板用于cDNA合成,可使用oligo(dT)引物或基因特异性引物。末端脱氧核苷酸转移酶(TdT)用于在第一链末端添加一段已知序列,如poly(A)。一旦加尾,第二链可使用poly(T)进行扩增。这种5'-RACE方案利用逆转录酶的TdT活性,允许在新合成的cDNA第一链末端进行非模板化的核苷酸添加。